Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs function by mimicking the physiological actions of GLP-1, a hormone produced by https://bookmarktiger.com/story20737981/reta-glucagon-like-peptide-1-receptor-agonists